Research ArticleAccepted Article
Acute coronary syndrome in idiopathic inflammatory myopathies: a population-based study
Valérie Leclair, John Svensson, Ingrid E. Lundberg and Marie Holmqvist
The Journal of Rheumatology March 2019, jrheum.181248; DOI: https://doi.org/10.3899/jrheum.181248
Valérie Leclair
From the Unit of Clinical Epidemiology, Department of Medicine, Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Division of Rheumatology, Jewish General Hospital, Montreal, Canada, 3Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Dr Lundberg was supported by grants from the Swedish Research Council, the Swedish Rheumatism Association, King Gustaf V 80 Year Foundation, and the Stockholm County Council (ALF project). Dr Holmqvist was supported by grants from the Swedish Rheumatism Association, the King Gustaf V 60 Year Foundation, the Nanna Svartz Foundation, and the Stockholm County Council (ALF project). Dr Lundberg has received honoraria from Bristol Myers Squibb and MedImmune and is currently receiving a research grant from Bristol Myers Squibb and from Astra Zeneca for projects unrelated to the present manuscript. No reference is made to specific products in our work, nor do we suggest therapeutic choices in our conclusions. The other authors declare no competing interests. Address correspondence to Valérie Leclair, MD, Karolinska Institutet, Unit of Clinical Epidemiology, Karolinska Hospital T2, SE-17176, Stockholm.
John Svensson
From the Unit of Clinical Epidemiology, Department of Medicine, Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Division of Rheumatology, Jewish General Hospital, Montreal, Canada, 3Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Dr Lundberg was supported by grants from the Swedish Research Council, the Swedish Rheumatism Association, King Gustaf V 80 Year Foundation, and the Stockholm County Council (ALF project). Dr Holmqvist was supported by grants from the Swedish Rheumatism Association, the King Gustaf V 60 Year Foundation, the Nanna Svartz Foundation, and the Stockholm County Council (ALF project). Dr Lundberg has received honoraria from Bristol Myers Squibb and MedImmune and is currently receiving a research grant from Bristol Myers Squibb and from Astra Zeneca for projects unrelated to the present manuscript. No reference is made to specific products in our work, nor do we suggest therapeutic choices in our conclusions. The other authors declare no competing interests. Address correspondence to Valérie Leclair, MD, Karolinska Institutet, Unit of Clinical Epidemiology, Karolinska Hospital T2, SE-17176, Stockholm.
Ingrid E. Lundberg
From the Unit of Clinical Epidemiology, Department of Medicine, Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Division of Rheumatology, Jewish General Hospital, Montreal, Canada, 3Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Dr Lundberg was supported by grants from the Swedish Research Council, the Swedish Rheumatism Association, King Gustaf V 80 Year Foundation, and the Stockholm County Council (ALF project). Dr Holmqvist was supported by grants from the Swedish Rheumatism Association, the King Gustaf V 60 Year Foundation, the Nanna Svartz Foundation, and the Stockholm County Council (ALF project). Dr Lundberg has received honoraria from Bristol Myers Squibb and MedImmune and is currently receiving a research grant from Bristol Myers Squibb and from Astra Zeneca for projects unrelated to the present manuscript. No reference is made to specific products in our work, nor do we suggest therapeutic choices in our conclusions. The other authors declare no competing interests. Address correspondence to Valérie Leclair, MD, Karolinska Institutet, Unit of Clinical Epidemiology, Karolinska Hospital T2, SE-17176, Stockholm.
Marie Holmqvist
From the Unit of Clinical Epidemiology, Department of Medicine, Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Division of Rheumatology, Jewish General Hospital, Montreal, Canada, 3Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Dr Lundberg was supported by grants from the Swedish Research Council, the Swedish Rheumatism Association, King Gustaf V 80 Year Foundation, and the Stockholm County Council (ALF project). Dr Holmqvist was supported by grants from the Swedish Rheumatism Association, the King Gustaf V 60 Year Foundation, the Nanna Svartz Foundation, and the Stockholm County Council (ALF project). Dr Lundberg has received honoraria from Bristol Myers Squibb and MedImmune and is currently receiving a research grant from Bristol Myers Squibb and from Astra Zeneca for projects unrelated to the present manuscript. No reference is made to specific products in our work, nor do we suggest therapeutic choices in our conclusions. The other authors declare no competing interests. Address correspondence to Valérie Leclair, MD, Karolinska Institutet, Unit of Clinical Epidemiology, Karolinska Hospital T2, SE-17176, Stockholm.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Accepted manuscript
Acute coronary syndrome in idiopathic inflammatory myopathies: a population-based study
Valérie Leclair, John Svensson, Ingrid E. Lundberg, Marie Holmqvist
The Journal of Rheumatology Mar 2019, jrheum.181248; DOI: 10.3899/jrheum.181248